190 Results

People

  1. Saltz
    Saltz
  2. Kelsen
    Kelsen
  3. Bajorin
    Bajorin
  4. O'Reilly
    O'Reilly
  5. Abrey
    Abrey
  6. Marks
    Marks
  7. Aghajanian
    Aghajanian
  8. Ilson
    Ilson
  9. De Angelis
    De Angelis
  10. Kelly
    Kelly

Groups

  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)
  7. Hematologic Malignancies, Division of (29)
  8. Survivorship Research (27)
  9. Genitourinary Oncology Service (25)
  10. Surgery (25)
  1. "dehydration"
Formats
  1. Journal Article (185)
  2. Review (2)
  3. Book Section (1)
  4. Conference Paper (1)
  5. Editorial (1)
Groups
  1. Department of Medicine (143)
  2. Solid Tumor Oncology Division (115)
  3. Gastrointestinal Oncology Service (39)
  4. Epidemiology and Biostatistics (31)
  5. Biostatistics Service (29)
  6. Center for Pancreatic Cancer Research (29)

More Groups

People
  1. Leonard Saltz (12)
  2. David Kelsen (10)
  3. Dean Bajorin (9)
  4. Eileen O'Reilly (9)
  5. Lauren Abrey (8)
  6. Paul Marks (8)

More People

Years
  1. 2025 (1)
  2. 2024 (11)
  3. 2023 (7)
  4. 2022 (2)
  5. 2021 (6)
  6. 2020 (11)

More Years

Publications
  1. Cancer (17)
  2. Journal of Clinical Oncology (16)
  3. Lancet Oncology (14)
  4. Gynecologic Oncology (10)
  5. Investigational New Drugs (10)
  6. Clinical Cancer Research (9)

More Publications

Publishers
  1. Elsevier Inc. (31)
  2. Springer (21)
  3. Wiley Blackwell (20)
  4. American Society of Clinical Oncology (16)
  5. Elsevier Science, Inc. (16)
  6. Oxford University Press (16)

More Publishers

Results (190)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 dose-escalation study of irinotecan in combination with 17-allylamino-17-demethoxygeldanamycin in patients with solid tumors
    Journal Article

    Tse, A. N.; Klimstra, D. S.; Gonen, M.; Shah, M.; Sheikh, T.; Sikorski, R.; Carvajal, R.; Mui, J.; Tipian, C.; O'reilly, E.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207
    Journal Article

    Rosenberg, J. E.; Halabi, S.; Sanford, B. L.; Himelstein, A. L.; Atkins, J. N.; Hohl, R. J.; Millard, F.; Bajorin, D. F.; Small, E. J.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update
    Journal Article

    Rizzo, J. D.; Somerfield, M. R.; Hagerty, K. L.; Seidenfeld, J.; Bohlius, J.; Bennett, C. L.; Cella, D. F.; Djulbegovic, B.; Goode, M. J.; Jakubowski, A. A.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • A phase II trial of cisplatin, fixed dose-rate gemcitabine and gefitinib for advanced urothelial tract carcinoma: Results of the Cancer and Leukaemia Group B 90102
    Journal Article

    Philips, G. K.; Halabi, S.; Sanford, B. L.; Bajorin, D.; Small, E. J.
    BJU International (2008)

    Fulltext@MSK | Save
  • Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Kondagunta, G. V.; Schwartz, L.; Ishill, N.; Bacik, J.; Deluca, J.; Russo, P.; Motzer, R. J.
    Investigational New Drugs (2008)

    Fulltext@MSK | Save
  • A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: An interim analysis
    Journal Article

    Mohile, N. A.; Forsyth, P.; Stewart, D.; Raizer, J. J.; Paleologos, N.; Kewalramani, T.; Louis, D. N.; Cairncross, J. G.; Abrey, L. E.
    Journal of Neuro-Oncology (2008)

    Fulltext@MSK | Save
  • A phase II study of cetuximab/paclitaxel/carboplatin for the initial treatment of advanced-stage ovarian, primary peritoneal, or fallopian tube cancer
    Journal Article

    Konner, J.; Schilder, R. J.; DeRosa, F. A.; Gerst, S. R.; Tew, W. P.; Sabbatini, P. J.; Hensley, M. L.; Spriggs, D. R.; Aghajanian, C. A.
    Gynecologic Oncology (2008)

    Fulltext@MSK | Save
  • Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (Romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromes
    Journal Article

    Klimek, V. M.; Fircanis, S.; Maslak, P.; Guernah, I.; Baum, M.; Wu, N.; Panageas, K.; Wright, J. J.; Pandolfi, P. P.; Nimer, S. D.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • Gemcitabine and cisplatin in unresectable malignant mesothelioma of the pleura: A phase II study of the Southwest Oncology Group (SWOG 9810)
    Journal Article

    Kalmadi, S. R.; Rankin, C.; Kraut, M. J.; Jacobs, A. D.; Petrylak, D. P.; Adelstein, D. J.; Keohan, M. L.; Taub, R. N.; Borden, E. C.
    Lung Cancer (2008)

    Fulltext@MSK | Save
  • A phase I trial of pemetrexed plus gemcitabine given biweekly with B-vitamin support in solid tumor malignancies or advanced epithelial ovarian cancer
    Journal Article

    Hensley, M. L.; Larkin, J.; Fury, M.; Gerst, S.; Tai, D. F.; Sabbatini, P.; Konner, J.; Orlando, M.; Goss, T. L.; Aghajanian, C. A.
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save